You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – Oncocyte announced Thursday its DetermaRx molecular diagnostic test for non-small cell lung cancer (NSCLC) received coverage from Medicare Administrative Contractor Palmetto GBA.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.